Nabilone

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

7 API Suppliers, 2 USDMF, 2 NDC API, 5 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

13 Dossiers, 1 FDA Orange Book, 11 Canada, 1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers, 9 BASF, 8 Roquette, 4 ACG Worldwide, 3 Lonza Capsugel, 3 SPI Pharma, 2 Ingredion Pharma Solutions, 2 Gangwal Chemicals, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Gangwal Healthcare, 1 Pharmatrans-Sanaq, 1 Seppic, 1 Microlex e.U, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Boai NKY Pharmaceuticals Ltd, 1 Ulanqab Kema New Material, 1 Kerry, 1 Qualicaps

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 9 Direct Compression, 8 Empty Capsules, 7 Solubilizers, 6 Granulation, 5 Coating Systems & Additives, 5 Disintegrants & Superdisintegrants, 5 Controlled & Modified Release, 4 Taste Masking, 3 Chewable & Orodispersible Aids, 3 Film Formers & Plasticizers, 3 Co-Processed Excipients, 2 Thickeners and Stabilizers, 2 Parenteral

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions

6 US Medicaid Prescriptions

DIGITAL CONTENT

1 Data Compilations & Company Tracker #PharmaFlow

1 Data Compilations & Company Tracker #PharmaFlow

Full Screen View

Adtech Pharma

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Ault Global Holdings Announces Agreement to Acquire up to 40% of Adtech Pharma, Inc.

Details:

NB-110 comprises of a synthetic cannabinoid Nabilone in the absence of any preservative and its formulation mimics a human tear to drive efficacious delivery through the cornea to the retina and optical nerves in the back of eye.

Lead Product(s): Nabilone

Therapeutic Area: Ophthalmology Product Name: NB-110

Highest Development Status: PreclinicalProduct Type: Small molecule

Partner/Sponsor/Collaborator: Ault Global Holdings

Deal Size: $3.0 million Upfront Cash: Undisclosed

Deal Type: Acquisition June 28, 2021

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Drugs in Development News & Deals for Nabilone

Nabilone

Nabilone

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

7 API Suppliers

2 USDMF

2 NDC API

5 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

13 Dossiers

1 FDA Orange Book

11 Canada

1 Listed Dossiers

RELATED EXCIPIENT COMPANIES

Suppliers

9 BASF

8 Roquette

4 ACG Worldwide

3 Lonza Capsugel

3 SPI Pharma

2 Ingredion Pharma Solutions

2 Gangwal Chemicals

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Gangwal Healthcare

1 Pharmatrans-Sanaq

1 Seppic

1 Microlex e.U

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Boai NKY Pharmaceuticals Ltd

1 Ulanqab Kema New Material

1 Kerry

1 Qualicaps

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

9 Direct Compression

8 Empty Capsules

7 Solubilizers

6 Granulation

5 Coating Systems & Additives

5 Disintegrants & Superdisintegrants

5 Controlled & Modified Release

4 Taste Masking

3 Chewable & Orodispersible Aids

3 Film Formers & Plasticizers

3 Co-Processed Excipients

2 Thickeners and Stabilizers

2 Parenteral

GLOBAL SALES INFORMATION

6 US Medicaid Prescriptions

DIGITAL CONTENT

1 Data Compilations & Company Tracker #PharmaFlow

API SUPPLIERS

API REF. PRICE (USD / KG)

INTERMEDIATES

DOSSIERS // FDF

GLOBAL SALES (USD Million)

EXCIPIENTS

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

REF STANDARD

SERVICES

Ault Global Holdings Announces Agreement to Acquire up to 40% of Adtech Pharma, Inc.

What are you looking for?